Funding for this research was provided by:
Jilin Department of Health (3R219C043428)
Received: 11 September 2019
Accepted: 30 June 2020
First Online: 11 July 2020
Ethics approval and consent to participate
: The research protocol was approved by the ethics committee of The First Hospital of Jilin University. All study participants provided written informed consent, and all experiments rigorously followed the Declaration of Helsinki principles.
: We agree to publication in the Cancer Cell International.
: All of the authors declare no competing interests.